These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

230 related items for PubMed ID: 14535878

  • 1. Expression of carbonic anhydrase IX in human pancreatic cancer.
    Juhász M, Chen J, Lendeckel U, Kellner U, Kasper HU, Tulassay Z, Pastorekova S, Malfertheiner P, Ebert MP.
    Aliment Pharmacol Ther; 2003 Oct 15; 18(8):837-46. PubMed ID: 14535878
    [Abstract] [Full Text] [Related]

  • 2. Roles of Carbonic Anhydrase IX in Development of Pancreatic Cancer.
    Li Y, Dong M, Sheng W, Huang L.
    Pathol Oncol Res; 2016 Apr 15; 22(2):277-86. PubMed ID: 26224207
    [Abstract] [Full Text] [Related]

  • 3. Hypoxia induced CA9 inhibitory targeting by two different sulfonamide derivatives including acetazolamide in human glioblastoma.
    Said HM, Hagemann C, Carta F, Katzer A, Polat B, Staab A, Scozzafava A, Anacker J, Vince GH, Flentje M, Supuran CT.
    Bioorg Med Chem; 2013 Jul 01; 21(13):3949-57. PubMed ID: 23706268
    [Abstract] [Full Text] [Related]

  • 4. Expression of carbonic anhydrase 9 at the invasion front of gastric cancers.
    Chen J, Röcken C, Hoffmann J, Krüger S, Lendeckel U, Rocco A, Pastorekova S, Malfertheiner P, Ebert MP.
    Gut; 2005 Jul 01; 54(7):920-7. PubMed ID: 15951534
    [Abstract] [Full Text] [Related]

  • 5. Selective inhibition of carbonic anhydrase IX over carbonic anhydrase XII in breast cancer cells using benzene sulfonamides: Disconnect between activity and growth inhibition.
    Mboge MY, Chen Z, Wolff A, Mathias JV, Tu C, Brown KD, Bozdag M, Carta F, Supuran CT, McKenna R, Frost SC.
    PLoS One; 2018 Jul 01; 13(11):e0207417. PubMed ID: 30452451
    [Abstract] [Full Text] [Related]

  • 6. Selective inhibition of carbonic anhydrase IX decreases cell proliferation and induces ceramide-mediated apoptosis in human cancer cells.
    Cianchi F, Vinci MC, Supuran CT, Peruzzi B, De Giuli P, Fasolis G, Perigli G, Pastorekova S, Papucci L, Pini A, Masini E, Puccetti L.
    J Pharmacol Exp Ther; 2010 Sep 01; 334(3):710-9. PubMed ID: 20519553
    [Abstract] [Full Text] [Related]

  • 7. Carbonic anhydrase IX as a specific biomarker for clear cell renal cell carcinoma: comparative study of Western blot and immunohistochemistry and implications for diagnosis.
    Giménez-Bachs JM, Salinas-Sánchez AS, Serrano-Oviedo L, Nam-Cha SH, Rubio-Del Campo A, Sánchez-Prieto R.
    Scand J Urol Nephrol; 2012 Oct 01; 46(5):358-64. PubMed ID: 22571179
    [Abstract] [Full Text] [Related]

  • 8. Carbonic anhydrase IX, an endogenous hypoxia marker, expression in head and neck squamous cell carcinoma and its relationship to hypoxia, necrosis, and microvessel density.
    Beasley NJ, Wykoff CC, Watson PH, Leek R, Turley H, Gatter K, Pastorek J, Cox GJ, Ratcliffe P, Harris AL.
    Cancer Res; 2001 Jul 01; 61(13):5262-7. PubMed ID: 11431368
    [Abstract] [Full Text] [Related]

  • 9. Biodistribution and pharmacokinetics of 125I-labeled monoclonal antibody M75 specific for carbonic anhydrase IX, an intrinsic marker of hypoxia, in nude mice xenografted with human colorectal carcinoma.
    Chrastina A, Závada J, Parkkila S, Kaluz S, Kaluzová M, Rajcáni J, Pastorek J, Pastoreková S.
    Int J Cancer; 2003 Jul 20; 105(6):873-81. PubMed ID: 12767076
    [Abstract] [Full Text] [Related]

  • 10. Expression of carbonic anhydrase IX in astrocytic tumors predicts poor prognosis.
    Haapasalo JA, Nordfors KM, Hilvo M, Rantala IJ, Soini Y, Parkkila AK, Pastoreková S, Pastorek J, Parkkila SM, Haapasalo HK.
    Clin Cancer Res; 2006 Jan 15; 12(2):473-7. PubMed ID: 16428489
    [Abstract] [Full Text] [Related]

  • 11. Carbonic anhydrase inhibitors: the first selective, membrane-impermeant inhibitors targeting the tumor-associated isozyme IX.
    Pastorekova S, Casini A, Scozzafava A, Vullo D, Pastorek J, Supuran CT.
    Bioorg Med Chem Lett; 2004 Feb 23; 14(4):869-73. PubMed ID: 15012984
    [Abstract] [Full Text] [Related]

  • 12. Microvessel density, endothelial-cell proliferation and carbonic anhydrase IX expression in haematological malignancies, bone-marrow metastases and monoclonal gammopathy of undetermined significance.
    De Raeve HR, Vermeulen PB, Vanderkerken K, Harris AL, Van Marck E.
    Virchows Arch; 2004 Jul 23; 445(1):27-35. PubMed ID: 15168117
    [Abstract] [Full Text] [Related]

  • 13. Carbonic anhydrase inhibitors: inhibition of the tumor-associated isozyme IX with aromatic and heterocyclic sulfonamides.
    Vullo D, Franchi M, Gallori E, Pastorek J, Scozzafava A, Pastorekova S, Supuran CT.
    Bioorg Med Chem Lett; 2003 Mar 24; 13(6):1005-9. PubMed ID: 12643899
    [Abstract] [Full Text] [Related]

  • 14. Carbonic anhydrase inhibitors. Inhibition of cytosolic isozymes I and II and transmembrane, cancer-associated isozyme IX with lipophilic sulfonamides.
    Franchi M, Vullo D, Gallori E, Pastorek J, Russo A, Scozzafava A, Pastorekova S, Supuran CT.
    J Enzyme Inhib Med Chem; 2003 Aug 24; 18(4):333-8. PubMed ID: 14567548
    [Abstract] [Full Text] [Related]

  • 15. Evaluation of carbonic anhydrase IX as a therapeutic target for inhibition of breast cancer invasion and metastasis using a series of in vitro breast cancer models.
    Ward C, Meehan J, Mullen P, Supuran C, Dixon JM, Thomas JS, Winum JY, Lambin P, Dubois L, Pavathaneni NK, Jarman EJ, Renshaw L, Um IH, Kay C, Harrison DJ, Kunkler IH, Langdon SP.
    Oncotarget; 2015 Sep 22; 6(28):24856-70. PubMed ID: 26259239
    [Abstract] [Full Text] [Related]

  • 16. Carbonic anhydrase inhibitors: synthesis and inhibition of cytosolic/tumor-associated carbonic anhydrase isozymes I, II, and IX with sulfonamides incorporating thioureido-sulfanilyl scaffolds.
    Puccetti L, Fasolis G, Cecchi A, Winum JY, Gamberi A, Montero JL, Scozzafava A, Supuran CT.
    Bioorg Med Chem Lett; 2005 May 02; 15(9):2359-64. PubMed ID: 15837325
    [Abstract] [Full Text] [Related]

  • 17. N-β-glycosyl sulfamides are selective inhibitors of the cancer associated carbonic anhydrase isoforms IX and XII.
    Rodríguez OM, Maresca A, Témpera CA, Bravo RD, Colinas PA, Supuran CT.
    Bioorg Med Chem Lett; 2011 Aug 01; 21(15):4447-50. PubMed ID: 21723123
    [Abstract] [Full Text] [Related]

  • 18. Carbonic anhydrase-IX inhibition enhances the efficacy of hexokinase II inhibitor for hepatocellular carcinoma in a murine model.
    Cho EJ, Yu SJ, Kim K, Cho H, Cho YY, Lee YB, Lee JH, Kim YJ, Youn H, Yoon JH.
    J Bioenerg Biomembr; 2019 Apr 01; 51(2):121-129. PubMed ID: 30746618
    [Abstract] [Full Text] [Related]

  • 19. Carbonic anhydrase inhibitors. Inhibition of the cytosolic and tumor-associated carbonic anhydrase isozymes I, II, and IX with a series of 1,3,4-thiadiazole- and 1,2,4-triazole-thiols.
    Almajan GL, Innocenti A, Puccetti L, Manole G, Barbuceanu S, Saramet I, Scozzafava A, Supuran CT.
    Bioorg Med Chem Lett; 2005 May 02; 15(9):2347-52. PubMed ID: 15837323
    [Abstract] [Full Text] [Related]

  • 20. Immunotargeting of human cervical carcinoma xenograft expressing CA IX tumor-associated antigen by 125I-labeled M75 monoclonal antibody.
    Chrastina A, Pastoreková S, Pastorek J.
    Neoplasma; 2003 May 02; 50(1):13-21. PubMed ID: 12687273
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.